Similarly, lateral ventricle administration, but not caudal vein injection of BMSC-EVs, improves AD-like behavioral performance in STZ-injected mice; this mechanism might be involved in the regulation of glial activation and its associated neuroinflammation and BDNF-related neuropathological changes in the hippocampus [155]. This evidence concerns the gene BDNF and Alzheimer disease.